These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 11251569)

  • 41. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes.
    Nakase K; Okamoto Y; Aoki S; Noguchi N
    J Dermatol; 2018 Mar; 45(3):340-343. PubMed ID: 29235673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes.
    Oprica C; Nord CE;
    Clin Microbiol Infect; 2005 Mar; 11(3):204-13. PubMed ID: 15715718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study.
    Coates P; Vyakrnam S; Eady EA; Jones CE; Cove JH; Cunliffe WJ
    Br J Dermatol; 2002 May; 146(5):840-8. PubMed ID: 12000382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C; Ergin S; Kaleli I; Kaçar N; Sengül M; Erdoğan BS
    J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
    [No Abstract]   [Full Text] [Related]  

  • 45. Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.
    Sheffer-Levi S; Rimon A; Lerer V; Shlomov T; Coppenhagen-Glazer S; Rakov C; Zeiter T; Nir-Paz R; Hazan R; Molho-Pessach V
    Acta Derm Venereol; 2020 Oct; 100(17):adv00295. PubMed ID: 33021324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
    Akamatsu H; Nishijima S; Takahashi M; Ushijima T; Asada Y
    J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial susceptibility and phylogenetic analysis of Propionibacterium acnes isolated from acne patients in Japan between 2013 and 2015.
    Nakase K; Hayashi N; Akiyama Y; Aoki S; Noguchi N
    J Dermatol; 2017 Nov; 44(11):1248-1254. PubMed ID: 28623856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
    Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H
    J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries.
    Oprica C; Löfmark S; Lund B; Edlund C; Emtestam L; Nord CE
    Anaerobe; 2005 Jun; 11(3):137-43. PubMed ID: 16701544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV.
    Nakase K; Sakuma Y; Nakaminami H; Noguchi N
    Anaerobe; 2016 Dec; 42():166-171. PubMed ID: 27793740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris.
    Delost GR; Delost ME; Armile J; Lloyd J
    J Am Acad Dermatol; 2016 Apr; 74(4):673-8. PubMed ID: 26777099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bactericidal activity and post-antibiotic effect of ozenoxacin against Propionibacterium acnes.
    Kanayama S; Okamoto K; Ikeda F; Ishii R; Matsumoto T; Hayashi N; Gotoh N
    J Infect Chemother; 2017 Jun; 23(6):374-380. PubMed ID: 28389164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review of Propionibacterium acnes resistance to systemic antibiotics.
    Cooper AJ
    Med J Aust; 1998 Sep; 169(5):259-61. PubMed ID: 9762064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transferable Multidrug-Resistance Plasmid Carrying a Novel Macrolide-Clindamycin Resistance Gene,
    Aoki S; Nakase K; Nakaminami H; Wajima T; Hayashi N; Noguchi N
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic resistance patterns of aerobic coryneforms and furazolidone-resistant Gram-positive cocci from the skin surface of the human axilla and fourth toe cleft.
    Eady EA; Coates P; Ross JI; Ratyal AH; Cove JH
    J Antimicrob Chemother; 2000 Aug; 46(2):205-13. PubMed ID: 10933642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
    Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
    Lim YH; Kim IH; Seo JJ
    J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
    Noyon V; Legallou F; Richet H; Dreno B
    Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis.
    Christensen GJ; Scholz CF; Enghild J; Rohde H; Kilian M; Thürmer A; Brzuszkiewicz E; Lomholt HB; Brüggemann H
    BMC Genomics; 2016 Feb; 17():152. PubMed ID: 26924200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.